Braha Adina, Simion Amanda, Timar Romulus, Timar Bogdan
Department of Second Internal Medicine-Diabetes, Nutrition, Metabolic Diseases, and Systemic Rheumatology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Department of Diabetes, Nutrition and Metabolic Diseases Clinic, "Pius Brînzeu" Emergency Clinical County University Hospital, 300723 Timisoara, Romania.
J Clin Med. 2024 Jan 24;13(3):676. doi: 10.3390/jcm13030676.
Over one-third of patients living with diabetes will develop ocular disease during their lifetime. The present study analyzes the association between metabolic and anthropometric markers, associated comorbidities, and intraocular pressure (IOP) in patients with type 2 diabetes mellitus (DM).
The retrospective study included 87 adult patients with type 2 DM who underwent routine eye examinations and blood/urine tests.
67.9% of the patients had an IOP > 14.5 mmHg and only 41.3% had an HbA1c < 7%. In a multivariate regression analysis, the mean IOP was associated with diabetes duration in subjects with a disease duration < 15 years and an HbA1c < 7% (adjusted R = 0.29, = 0.008). Also, patients with shorter diabetes duration and optimal glucose control had a lower mean IOP than patients with a higher HbA1c (mean IOP 15.1 mmHG vs. 18.9 mmHg, = 0.04). The patient's age, anthropometric or metabolic markers, associated comorbidities like hypertension (HTN) or retinal angiosclerosis, and diabetes therapies were not associated with IOP in this study.
Diabetes progression is directly associated with increased IOP. Avoiding clinical inertia and optimizing glycemic control could prevent or delay the increase of IOP. Routine eye examination should include measuring IOP, not only diabetic retinopathy screening.
超过三分之一的糖尿病患者在其一生中会患上眼部疾病。本研究分析了2型糖尿病(DM)患者的代谢和人体测量指标、相关合并症与眼压(IOP)之间的关联。
这项回顾性研究纳入了87例接受常规眼科检查及血液/尿液检查的成年2型糖尿病患者。
67.9%的患者眼压>14.5 mmHg,只有41.3%的患者糖化血红蛋白(HbA1c)<7%。在多变量回归分析中,病程<15年且HbA1c<7%的患者,平均眼压与糖尿病病程相关(调整后R = 0.29,P = 0.008)。此外,糖尿病病程较短且血糖控制良好的患者,其平均眼压低于HbA1c较高的患者(平均眼压15.1 mmHg对18.9 mmHg,P = 0.04)。在本研究中,患者的年龄、人体测量或代谢指标、高血压(HTN)或视网膜动脉硬化等相关合并症以及糖尿病治疗方法均与眼压无关。
糖尿病进展与眼压升高直接相关。避免临床惰性并优化血糖控制可预防或延缓眼压升高。常规眼科检查应包括测量眼压,而不仅仅是糖尿病视网膜病变筛查。